These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9623438

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modulation by catecholamine of hypothalamus-pituitary-adrenocortical (HPA) axis activity in morphine-tolerance and withdrawal.
    Martinez-Piñero MG, Milanes MV, Vargas ML.
    Gen Pharmacol; 1994 Jan; 25(1):187-92. PubMed ID: 8026704
    [Abstract] [Full Text] [Related]

  • 6. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
    Alcaraz C, Vargas ML, Milanés MV.
    Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
    [Abstract] [Full Text] [Related]

  • 7. Catecholaminergic activity and 3',5'-cyclic adenosine monophosphate levels in heart right ventricle after naloxone induced withdrawal.
    Milanés MV, Fuente T, Laorden ML.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):61-6. PubMed ID: 10651148
    [Abstract] [Full Text] [Related]

  • 8. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML, Fuertes G, González-Cuello A, Milanés MV.
    J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous changes in hypothalamic catecholamine levels and plasma corticosterone concentration in the rat after acute morphine and during tolerance.
    Milanés MV, Puig MM, Vargas ML.
    Neuropeptides; 1993 May; 24(5):279-84. PubMed ID: 8327071
    [Abstract] [Full Text] [Related]

  • 10. Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal-regulated kinase.
    Martínez-Laorden E, Hurle MA, Milanés MV, Laorden ML, Almela P.
    J Pharmacol Exp Ther; 2012 Sep; 342(3):665-75. PubMed ID: 22647273
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of protein kinase C but not protein kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis.
    Cerezo M, Laorden ML, Milanés MV.
    Eur J Pharmacol; 2002 Sep 27; 452(1):57-66. PubMed ID: 12323385
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence for a peripheral mechanism in cardiac opioid withdrawal.
    Milanés MV, Martinez MD, González-Cuello A, Laorden ML.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep 27; 364(3):193-8. PubMed ID: 11521160
    [Abstract] [Full Text] [Related]

  • 14. Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal.
    González-Cuello A, Milanés MV, Castells MT, Laorden ML.
    Br J Pharmacol; 2003 Feb 27; 138(4):626-33. PubMed ID: 12598416
    [Abstract] [Full Text] [Related]

  • 15. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
    Milanés MV, Laorden ML, Chapleur-Château M, Burlet A.
    J Pharmacol Exp Ther; 1998 May 27; 285(2):700-6. PubMed ID: 9580616
    [Abstract] [Full Text] [Related]

  • 16. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
    Almela P, Cerezo M, González-Cuello A, Milanés MV, Laorden ML.
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan 27; 374(4):293-303. PubMed ID: 17216288
    [Abstract] [Full Text] [Related]

  • 17. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal.
    Gonzalvez ML, Milanés MV, Martinez-Piñero MG, Marín MT, Vargas ML.
    Brain Res; 1994 Jun 06; 647(2):199-203. PubMed ID: 7922496
    [Abstract] [Full Text] [Related]

  • 18. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
    Navarro-Zaragoza J, Martínez-Laorden E, Mora L, Hidalgo J, Milanés MV, Laorden ML.
    Toxicol Appl Pharmacol; 2014 Feb 15; 275(1):28-35. PubMed ID: 24398105
    [Abstract] [Full Text] [Related]

  • 19. Changes in oxytocin content in rat brain during morphine withdrawal.
    Laorden ML, Milanés MV, Chapleur-Château M, Burlet A.
    Neuropeptides; 1998 Feb 15; 32(1):67-71. PubMed ID: 9571647
    [Abstract] [Full Text] [Related]

  • 20. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
    Navarro-Zaragoza J, Laorden ML, Milanés MV.
    Toxicology; 2014 Dec 04; 326():36-43. PubMed ID: 25308750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.